OUR TEAM
THE ADVISORY BOARD
Vaughn Burton
Chairman
Christopher Jennings
Shilpa Sharma
John Ashley
Philippe Schulligen
John Arnold
Accomplished Investment Leader & General Partner in Private Equity Expert in Healthcare, Transportation & Asset-Backed Financing Results-Driven with Strong Client Management Skills
High-achieving founder and Chief Executive Officer with over 20 years of extensive expertise in business growth, strategic partnerships, enterprise software, and go-to-market strategy.
Determined Senior Product Leader and Business Advisor with extensive expertise in software development, product management, business strategy, requirements analysis, and machine learning
Visionary CEO & Co-Founder in Medical Devices | 35+ Years of Driving Innovation and $1.25B+ in Returns | Expert in Scoliosis Solutions & Telehealth Advisory
Expert in Real Estate Investments, Fund Management, and Projects & Teams Leadership | PMP Certified | Forbes Council Contributor | Advocate for AI Innovation
Result-driven Vice President with over 20 years of extensive expertise in business transformation, product development, revenue growth, and financial modeling
Our collective of 10+ capital markets, legal, and compliance experts bring decades of deal experience across aerospace, fintech, healthcare, energy,
real estate, and technology.
Office Based: Atlanta Georgia 30328
International
+1 (888) 652-0752
Domestic
(678) 534-5033
Email: [email protected]
Site: www.thebitechnologies.com
Copyright BiTechnologies 2025. All rights reserved
Burton Investment Technologies, LP
BITECHNOLOGIES IS NOT A BROKER DEALER OR A THIRD PARTY CAPITAL RAISING FIRM. OUR OFFERINGS ARE SECURITIES THAT ARE OWNED AND MANAGED UNDER BITECHNOLOGIES. All securities offered by BiTechnologies are offered in reliance on exemptions from registration under the Securities Act, including but not limited to Rule 506(b) of Regulation D and Rule 144A, which allow the sale of securities to accredited investors and qualified institutional buyers (QIBs), respectively. These offerings are made through private placements only and are not registered with the SEC. The securities are subject to restrictions on transfer and resale, and investors must meet specific eligibility requirements as defined under SEC regulations.